Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics (Q47963812)
Jump to navigation
Jump to search
scientific article published on April 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics |
scientific article published on April 1, 2003 |
Statements
1 reference
Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics (English)
1 reference
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics (English)
1 reference
Qutayba Hamid
1 reference
Andrew Menzies-Gow
1 reference
Patrick Flood-Page
1 reference
Roma Sehmi
1 reference
John Burman
1 reference
Judah Denburg
1 reference
Douglas S. Robinson
1 April 2003
1 reference
1 reference
111
1 reference
4
1 reference
714-719
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference